InSysBio to present posters at AAIC 2022

events
Conference
July 27, 2022

July 27, 2022

InSysBio announces its participation in AAIC 2022 (Online). Alzheimer’s Association International Conference is held July 31 – August 4, 2022 in San Diego, USA and Online. InSysBio Neurodegeneration Diseases team presents three posters within its frames, namely:

Virtual Platform, Sunday, July 31, 2022: 7:00 AM – 11:55 PM

  • Poster #65408 "Application of quantitative systems pharmacology model of Alzheimer’s disease for simulation of efficacy of tyrosine kinase inhibitors" by Tatiana Karelina
  • Poster #63102 "The QSP model of TREM2 influences on inflammatory state of microglia in Alzheimer’s disease" by Stepan Lerner
  • Poster #65357 "Neurofilament L dynamics description in the model of tauopathy" by Polina Pchelintseva

Our latest posters: InSysBio posters

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Moscow, Russia (INSYSBIO LLC) and Cyprus (INSYSBIO CY Ltd). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

October 2025
MoTuWeThFrSaSu
  
1
2
1. 02 Oct 2025 13:23 InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP InSysBio announces their participation in BioTechX Europe 2025. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges"
3
4
5
6
7
8
9
10
11
12
13
14
15
16
1. 16 Oct 2025 12:13 InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
  
Upcoming Events
Tags
Latest News
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology